← Back to news
Y

Yahoo Finance

Palantir Billionaire Peter Thiel Sells Nvidia Stock -- 100% of His Portfolio Is Now Invested in 3 AI Stocks

Y

Palomar Holdings, Inc. (PLMR) Gains Analyst Support as JPMorgan and KBW Raise Targets

Y

Progyny, Inc. (PGNY) Supported by Analysts as Earnings Visibility Improves

Y

Analysts Expect Matador Resources Company (MTDR) to Navigate Lower Oil Prices Effectively

Y

Morgan Stanley Is Bullish on PTC Therapeutics, Inc. (PTCT) as Small-Cap Biotech Outlook Improves

Y

Wells Fargo See Upside for Genius Sports Limited (GENI) on Expanding Media and Advertising Opportunity

Y

TD Cowen is Bullish on Alignment Healthcare, Inc. (ALHC) After Medicare Advantage Update

Y

Mr. Gatti’s sold to franchisee

Y

Asian Stocks, Bonds Recover as Fears About U.S. Tariffs on Europe Ease

Y

Piper Sandler Highlights Arrowhead Pharmaceuticals, Inc. (ARWR) Pipeline With Upcoming Phase III Hypertriglyceridemia Data

Y

e.l.f Beauty, Inc. (ELF) Maintains Analyst Attention With 2026 Growth Potential

Y

Analysts See Mixed Outlook for Shift4 Payments, Inc. (FOUR) Amid Fintech Sector Risks

Y

Ubisoft shares tumble after 'Assassin's Creed' creator unveils restructuring, cancels games

Y

Barclays Is Bullish on UiPath, Inc. (PATH) Amid Stable IT Spending Outlook

Y

Analysts Highlight Chord Energy Corporation (CHRD)’s Disciplined Approach to Capital and Shareholder Returns

Y

Wells Fargo Is Bullish on Inspire Medical Systems, Inc. (INSP) Despite Short-Term Reimbursement Concerns

Y

Thailand Targets Early 2026 for Crypto ETF Regulations

Y

Jim Cramer Explains Why He Thinks NVIDIA’s Jensen Huang Is the “Greatest Technologist of Our Era”

Y

Jim Cramer on Micron CEO: “Sanjay’s Always Preferred Building in America, and That’s One of the Reasons Why I Salute Him”

Y

Jim Cramer on Constellation Energy: “The Fact Is That When the President Gets Involved, It’s Too Uncertain”

Y

Jim Cramer Says He “Would Be a Buyer of STMicro”

Y

Jim Cramer Says Medline “Stock Is Unbelievable” And Recommends Buying It

Y

Jim Cramer on Smith & Nephew: “This Group, I Do Not Like”

Y

Jim Cramer on UiPath: “You Might Have to Wait a Little Bit Longer, But I Think the Upside Is What Beckons There”

Y

Jim Cramer on Huntington Bancshares: “They’re Terrific”

Y

Jim Cramer on Alkermes: “I Think It’s a Hold, Maybe a Weak One”

Y

Jim Cramer on Super Micro: “Sell, I Don’t Need That”

Y

Jim Cramer Shows Bullish Sentiment Toward Oscar Health Because of CEO Mark Bertolini

Y

Jim Cramer on Ares Capital: “I Want to Be Very Careful There”

Y

Jim Cramer on Honeywell: “It’s Finally Getting Credit for All the Things It’s Doing”

Y

Jim Cramer on Simon Property’s CEO: “We Think David Simon’s the Best Mall Operator There Is”

Y

Jim Cramer on Crinetics: “That’s a Better Spec Than Aquestive”

Y

Jim Cramer on GE HealthCare: “I Just Don’t Think It’s What You Want to Own”

Y

Jim Cramer Says “Let’s Buy CVS, Not UnitedHealth”

Y

Jim Cramer on Aquestive Therapeutics: “I’m Not Sure If They Deserve the Benefit of the Doubt”

Y

Jim Cramer on FedEx Freight Spin-Off Plans: “This Deserves a Lot of Attention”

Y

Jim Cramer Says “When the Freight Market Turns Around, J.B.Hunt Should Be Able to Make a Fortune”

Y

Jim Cramer on Boeing: “It’s My Favorite Stock in the Charitable Trust”

Y

Jim Cramer Calls Lam Research the “Best of the Best” But Warns Against Buying Parabolic Moves

Y

Is It Too Late for a Roth Conversion? I'm 60 With $930k in My IRA and Have Started Social Security.

Y

Australia watchdog orders audit of fintech Airwallex on suspected compliance miss

Y

Housing Market’s Blue Christmas: Pending Sales Slide Most Since 2001

Y

CFP Board Taps K. Dane Snowden as Next CEO

Y

Fanuc Corporation ADR (FANUY) Shares Gain After Earnings Beat and Guidance Upgrade

Y

US stocks climb some more after Trump calls off his tariffs for Greenland

Y

JPMorgan Resumes Coverage of Chevron (CVX) with ‘Overweight’ Rating

Y

ConocoPhillips (COP) Downgraded at JPMorgan

Y

EOG Resources (EOG) Price Target Lowered by $7

Y

HF Sinclair (DINO) Price Target Reduced by $1, ‘Overweight’ Rating Maintained

Y

Exxon Mobil (XOM) Price Target Raised by $9 at JPMorgan

Y